Hextend is a Intravenous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Hospira, Inc.. The primary component is Hetastarch.
| Product ID | 0409-1555_62a15a9b-c395-4669-b6ae-52b814d25500 |
| NDC | 0409-1555 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Hextend |
| Generic Name | Hetastarch |
| Dosage Form | Injection, Solution |
| Route of Administration | INTRAVENOUS |
| Marketing Start Date | 2005-02-02 |
| Marketing Category | NDA / NDA |
| Application Number | BN200952 |
| Labeler Name | Hospira, Inc. |
| Substance Name | HETASTARCH |
| Active Ingredient Strength | 6 g/100mL |
| Pharm Classes | Plasma Volume Expander [EPC],Increased Intravascular Volume [PE],Osmotic Activity [MoA],Starch [CS] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |
| Marketing Start Date | 2005-02-02 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | BN200952 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2005-02-02 |
| Marketing Category | NDA |
| Application Number | BN200952 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2015-07-07 |
| Ingredient | Strength |
|---|---|
| HETASTARCH | 6 g/100mL |
| SPL SET ID: | fc79700c-6c3b-4998-8307-4dc8c81c5041 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0409-1555 | Hextend | HETASTARCH |
| 0409-7248 | Hetastarch in Sodium Chloride | HETASTARCH |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() HEXTEND 98714384 not registered Live/Pending |
Storyastic, LLC 2024-08-23 |
![]() HEXTEND 74678267 1964271 Live/Registered |
BIOTIME, INC. 1995-05-22 |